ID

18111

Descrizione

Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT00225056

collegamento

https://clinicaltrials.gov/show/NCT00225056

Keywords

versioni (1)
  1. 20/10/16 20/10/16 -
Caricato su

20 ottobre 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Metastatic Breast Cancer NCT00225056

Inglese

Eligibility Metastatic Breast Cancer NCT00225056

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
must have metastatic breast cancer
Descrizione

Carcinoma breast stage IV

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0278488
must have cytologically or pathologically confirmed invasive ductal or lobular carcinoma
Descrizione

Invasive Ductal Breast Carcinoma | Carcinoma, Lobular

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1134719
UMLS CUI [2]
C0206692
must have measurable or evaluable disease
Descrizione

Measurable Disease | Evaluable Disease

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1513041
UMLS CUI [2]
C1516986
ecog of 0-1
Descrizione

ECOG performance status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1520224
patients may have received 0, 1. or 2 prior treatments for metastatic breast cancer
Descrizione

Prior Therapy Quantity Carcinoma breast stage IV

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0278488
must have adequate organ function
Descrizione

organ function

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0678852
must be at least 19 years of age
Descrizione

Age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
peripheral neuropathy less than or equal to grade 1
Descrizione

Peripheral Neuropathy | CTCAE Grades

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0031117
UMLS CUI [2]
C1516728
must have voluntarily signed informed consent
Descrizione

Informed Consent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
patients with brain metastases are eligible provided that other measurable disease exists and brain lesions are controlled
Descrizione

Metastatic malignant neoplasm to brain | Measurable Disease | Lesion of brain Controlled

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0220650
UMLS CUI [2]
C1513041
UMLS CUI [3,1]
C0221505
UMLS CUI [3,2]
C2911690
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with other malignancies, except non melanoma of the skin, who have had any evidence of cancer within the last 5 years
Descrizione

Malignant Neoplasms | Skin carcinoma

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2]
C0699893
patients with psychiatric illness or other concurrent severe co-morbid medical condition that would preclude study completion
Descrizione

Mental disorder Excludes Clinical Trial Completion | Comorbidity Severe Excludes Clinical Trial Completion

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0004936
UMLS CUI [1,2]
C0332196
UMLS CUI [1,3]
C0008976
UMLS CUI [1,4]
C0205197
UMLS CUI [2,1]
C0009488
UMLS CUI [2,2]
C0205082
UMLS CUI [2,3]
C0332196
UMLS CUI [2,4]
C0008976
UMLS CUI [2,5]
C0205197
known uncontrolled existing coagulopathy
Descrizione

Blood Coagulation Disorder Uncontrolled

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0005779
UMLS CUI [1,2]
C0205318
patients with a history of severe hypersensitivity reaction to docetaxel, medications formulated with polysorbate 80 or 5-fluorouracil
Descrizione

severe allergy docetaxel | severe allergy Polysorbate 80 Formulation | severe allergy Fluorouracil Formulation

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C2945656
UMLS CUI [1,2]
C0246415
UMLS CUI [2,1]
C2945656
UMLS CUI [2,2]
C0032601
UMLS CUI [2,3]
C1705957
UMLS CUI [3,1]
C2945656
UMLS CUI [3,2]
C0016360
UMLS CUI [3,3]
C1705957
use of other investigational agents in the last 28 days
Descrizione

Investigational New Drugs

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0013230
pregnant or lactating women
Descrizione

Pregnancy | Breast Feeding

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
patients who are known hiv positive
Descrizione

HIV Seropositivity

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0019699
patients with life expectancy of less than 3 months
Descrizione

Life Expectancy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0023671
sexually active patients unwilling to practice reliable contraception during the study
Descrizione

Sex Behavior Contraceptive methods Unwilling

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0036864
UMLS CUI [1,2]
C0700589
UMLS CUI [1,3]
C0558080
Ritorna all'inizio della pagina

Similar models

Eligibility Metastatic Breast Cancer NCT00225056

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Carcinoma breast stage IV
Item
must have metastatic breast cancer
boolean
C0278488 (UMLS CUI [1])
Invasive Ductal Breast Carcinoma | Carcinoma, Lobular
Item
must have cytologically or pathologically confirmed invasive ductal or lobular carcinoma
boolean
C1134719 (UMLS CUI [1])
C0206692 (UMLS CUI [2])
Measurable Disease | Evaluable Disease
Item
must have measurable or evaluable disease
boolean
C1513041 (UMLS CUI [1])
C1516986 (UMLS CUI [2])
ECOG performance status
Item
ecog of 0-1
boolean
C1520224 (UMLS CUI [1])
Prior Therapy Quantity Carcinoma breast stage IV
Item
patients may have received 0, 1. or 2 prior treatments for metastatic breast cancer
boolean
C1514463 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0278488 (UMLS CUI [1,3])
organ function
Item
must have adequate organ function
boolean
C0678852 (UMLS CUI [1])
Age
Item
must be at least 19 years of age
boolean
C0001779 (UMLS CUI [1])
Peripheral Neuropathy | CTCAE Grades
Item
peripheral neuropathy less than or equal to grade 1
boolean
C0031117 (UMLS CUI [1])
C1516728 (UMLS CUI [2])
Informed Consent
Item
must have voluntarily signed informed consent
boolean
C0021430 (UMLS CUI [1])
Metastatic malignant neoplasm to brain | Measurable Disease | Lesion of brain Controlled
Item
patients with brain metastases are eligible provided that other measurable disease exists and brain lesions are controlled
boolean
C0220650 (UMLS CUI [1])
C1513041 (UMLS CUI [2])
C0221505 (UMLS CUI [3,1])
C2911690 (UMLS CUI [3,2])
Item Group
C0680251 (UMLS CUI)
Malignant Neoplasms | Skin carcinoma
Item
patients with other malignancies, except non melanoma of the skin, who have had any evidence of cancer within the last 5 years
boolean
C0006826 (UMLS CUI [1])
C0699893 (UMLS CUI [2])
Mental disorder Excludes Clinical Trial Completion | Comorbidity Severe Excludes Clinical Trial Completion
Item
patients with psychiatric illness or other concurrent severe co-morbid medical condition that would preclude study completion
boolean
C0004936 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0205197 (UMLS CUI [1,4])
C0009488 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0332196 (UMLS CUI [2,3])
C0008976 (UMLS CUI [2,4])
C0205197 (UMLS CUI [2,5])
Blood Coagulation Disorder Uncontrolled
Item
known uncontrolled existing coagulopathy
boolean
C0005779 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
severe allergy docetaxel | severe allergy Polysorbate 80 Formulation | severe allergy Fluorouracil Formulation
Item
patients with a history of severe hypersensitivity reaction to docetaxel, medications formulated with polysorbate 80 or 5-fluorouracil
boolean
C2945656 (UMLS CUI [1,1])
C0246415 (UMLS CUI [1,2])
C2945656 (UMLS CUI [2,1])
C0032601 (UMLS CUI [2,2])
C1705957 (UMLS CUI [2,3])
C2945656 (UMLS CUI [3,1])
C0016360 (UMLS CUI [3,2])
C1705957 (UMLS CUI [3,3])
Investigational New Drugs
Item
use of other investigational agents in the last 28 days
boolean
C0013230 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnant or lactating women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
HIV Seropositivity
Item
patients who are known hiv positive
boolean
C0019699 (UMLS CUI [1])
Life Expectancy
Item
patients with life expectancy of less than 3 months
boolean
C0023671 (UMLS CUI [1])
Sex Behavior Contraceptive methods Unwilling
Item
sexually active patients unwilling to practice reliable contraception during the study
boolean
C0036864 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0558080 (UMLS CUI [1,3])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial